Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
823 people get SNTA articles and Market Currents by email alert.
Get email alerts on SNTA »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Business Wire (May 15, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 16, 2013)
-
Business Wire (Apr 5, 2013)
-
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 13, 2013)
-
-
-
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 11, 2013)
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
Synta Readying 2 Key Lung Cancer TrialsLen Zehr • Wed, Apr 20, 2011 -
Putting a Price Tag on Synta's Lead Drug ActivitiesOhad Hammer • Sun, Mar 20, 2011
-
-
-
-
Evaluating Synta Pharmaceuticals' CashflowBrian Orelli • Mon, Mar 26, 2007 -
Recent IPO Synta Pharma Sees Strong Insider BuyingRichard Shonfeld • Tue, Feb 27, 2007
-
-
-
-
-
-
-
-
-
-
-
-
5 Healthcare Companies With Significant Recent Insider Buying (Part IV)Markus Aarnio • Wed, Nov 14, 2012
-
Investments In The Fight Against Cancer: The Analysts' ChoicesGlen S. Woods • Mon, Nov 5, 2012 -
-
-
-
-
5 Highly Shorted Small-Caps With Strong Insider And Institutional BuyingKapitall • Tue, Sep 18, 2012
-
-
-
Synta Pharmaceuticals Corp. Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
Synta Pharmaceuticals Corp. Q3 2009 Earnings Call TranscriptWed, Nov 4, 2009
-
Synta Pharmaceuticals Corp. Q3 2008 Earnings Call TranscriptThu, Nov 13, 2008
-
Synta Pharmaceuticals Corp. Q2 2008 Earnings Call TranscriptTue, Sep 2, 2008
-
Synta Pharmaceuticals Corp. Q1 2008 Earnings Call TranscriptTue, May 27, 2008
-
Synta Pharmaceuticals Corp. Q4 2007 Earnings Call TranscriptThu, Mar 20, 2008
-
Business Wire (May 15, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 16, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 13, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 11, 2013)
-
Business Wire (Dec 13, 2012)
-
Business Wire (Dec 12, 2012)
-
Business Wire (Nov 27, 2012)
-
Business Wire (Nov 26, 2012)
-
Business Wire (Nov 9, 2012)
-
Business Wire (Nov 7, 2012)
-
Business Wire (Nov 6, 2012)
-
Business Wire (Oct 24, 2012)
-
Business Wire (Sep 18, 2012)
SNTA vs. ETF Alternatives
Company Description
Currently, there's no company description for SNTA.
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Joshua Hayes
Big Wave Trading Portfolio Update And Top Current Holdings http://bit.ly/LEAhD2 SNTA FU MAGS VRNM BVSN PHMD AVD ANGI - View all 0 replies
-
- View all 5 replies
-
tuliptown: am long as well. What does the HUGE volume down mean to you? Who were the weak hands leaving and who are buying? agree data was good. -
-
TruffelPig
SNTA: I did read the data - they were actually pretty good; progression free time at least doubled, in some groups tripled - View all 3 replies
-
TruffelPig: Something similar happened to ECYT end of last year - the "expert" investors also sold and were WRONG.
-
TruffelPig: As a biochemist I pressed the buy button today! Price target $10 in the next 12 month. Good story.
-
- View all 0 replies
-
Jim Van Meerten
SNTA - 72% Barchart technical buy signal - 12 new highs and up 49.68% in the past year 0 Relative strength Index 72.23% - View all 1 replies
-
-
- View all 0 replies
LATEST REPLIES
-
- View all 5 replies
-
tuliptown: am long as well. What does the HUGE volume down mean to you? Who were the weak hands leaving and who are buying? agree data was good.
-
-
TruffelPig
SNTA: I did read the data - they were actually pretty good; progression free time at least doubled, in some groups tripled - View all 3 replies
-
TruffelPig: Something similar happened to ECYT end of last year - the "expert" investors also sold and were WRONG.
-
TruffelPig: As a biochemist I pressed the buy button today! Price target $10 in the next 12 month. Good story.
-
Jim Van Meerten
SNTA - 72% Barchart technical buy signal - 12 new highs and up 49.68% in the past year 0 Relative strength Index 72.23% - View all 1 replies
-
-
Todd Theman
Looking for an entry point into SNTA. Is $4 reasonable? Looking for a bump in advance of ASCO this summer. - View all 1 replies
-
PYRAMIDHUNT: An insider bought $5,000,000 of shares at $4.40 just a couple months ago.
-
The Scientist
Market potential for SNTA ganetespib is ridiculous. If it works in half the cancers they are studying, $10B+ potential. - View all 8 replies
-
-
The Scientist: I am a MD, PhD. I used to spend all my time in a molecular biology lab. Now I practice medicine.